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Introduction 67
Zaire ebolavirus (EBOV) is one of five species of ebolaviruses within the Filoviridae family. 68 EBOV continues to cause significant outbreaks in sub-Saharan Africa with case fatality rates as 69 high as 90% [ internalization of viral particles into the endosomal compartment [9, 15] . This mechanism of 80 viral entry has been termed apoptotic mimicry [16] . Following endosomal uptake of filovirions, 81 proteolytic GP processing occurs, thereby allowing GP to interact with its endosomal cognate 82 receptor, Niemann Pick C1 [17] [18] [19] [20] [21] . 83 84
One important family of PS receptors is the T-cell immunoglobulin mucin domain (TIM) 85
family. TIM family members, encoded by the Havcr family of genes, contribute to the uptake 86 of apoptotic bodies to clear dying cells from tissues and the circulation [22] [23] [24] . TIM proteins 87 are type 1, cell surface glycoproteins. Three family members are present in humans (hTIM-1, 88
hTIM-3 and hTIM-4) and four in mice (TIM-1, TIM-2, TIM-3 and TIM-4) [25] . hTIM-1 was 89 pathogenesis. Consistent with reduced overall virus loads, proinflammatory chemokine profiles 136 were also lower in the EBOV GP/rVSV infected TIM-1-deficient mice at late time points 137 following infection. Finally, to directly evaluate whether enhanced survival and reduced 138 inflammation in TIM-1-deficient mice was associated with T cell activation as previously 139
reported [34] , we depleted T cells in EBOV GP/rVSV infected TIM-1-sufficient or -deficient 140 mice and found that T cell depletion did not alter EBOV GP/rVSV pathogenesis. In total, our 141 studies provide evidence that TIM-1 associated pathogenesis correlated with enhanced virus 142 load at late times during infection, consistent with TIM-1 having an important role as a receptor 143
for EBOV in vivo. 144 were produced in normal Mendelian ratios. Genomic DNA from mouse tail-clips was assessed 165
Materials and Methods
by PCR for genotypes. The primers and protocol for Ifnar -/-screening has been previously 166 EBOV ∆O or the native VSV G glycoprotein (EBOV GP/rVSV-GFP, EBOV GP∆O/rVSV-190 GFP and G/rVSV-GFP, respectively) using concentrations of virus noted in the figure legends. from with EBOV GP∆O/rVSV. Prior to euthanasia, mice were anesthetized with isoflurane to 205 perform retro-orbital bleeds for serum. Mice were euthanized and perfused with 10 mL of PBS 206 through the heart and organs harvested, weighed and frozen at -80ºC. To determine virus titers, 207 organs or sera were thawed and organs were homogenized in PBS and filtered through a 0.45 µ 208 syringe filter. Viral titers were determined by end point dilution on Vero cell as previously 209 In contrast to our EBOV GP/rVSV findings, we observed no difference in the survival curve 289 between the two strains of mice (Fig. 1C) . Since it is likely that VSV bearing it native GP is 290 more pathogenic than a recombinant VSV containing a different viral GP, we also evaluated 291 mortality associated with different doses of VSV and found that administration of as little as 10 The effect of TIM-1 expression on viremia and organ viral loads following i.v. EBOV 304 GP∆O/rVSV infection was examined in serum and organs harvested 1, 3 or 5 days following 305 infection (Fig. 2) . Viremia and infectious virus in various organs were quantified by endpoint 306 dilution titering on Vero cells, a highly permissive cell line for EBOV GP/rVSV. At early times 307 . CC-BY 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/466102 doi: bioRxiv preprint during infection, no difference in viremia or virus load was observed in most organs of TIM-1 308 versus control mice. However, by day 5 of EBOV GPΔO/rVSV infection, TIM-1 -/-mice had a 309 100-fold reduction in viremia compared to control mice (Fig. 2) and a similar trend was observed 310 during infections with full length EBOV GP/rVSV (Supplement Fig. 3 ). In parallel, levels of 311 infectious virus in liver, kidney, and adrenal gland were also significantly reduced. Studies at day 312 5 of infection also indicated that EBOV GP∆O/rVSV loads were much reduced in the brain of 313 TIM-1 -/-mice and trended lower in the testis (Supplement Fig. 4A and B lower RNA expression profiles of selected, well-characterized cytokines, levels in the spleen, 337 liver and kidney were examined prior to and following EBOV GP∆O/rVSV infection. Organs 338 were harvested at day 3 and 5 following infection and total RNA was isolated and amplified for 339 the mRNA of the housekeeping gene, HPRT, and the cytokines IL-6, TNF, IL-12 and IL-10. 340
Cytokine expression levels were normalized against HPRT expression. Overall, baseline values 341 of the organ cytokine expression from uninfected control and TIM-1 -/-mice were low with little 342 difference between the strains (Fig. 3) . While at day 5 TNF was significantly higher in spleen of 343 control mice, in general during the infection cytokine expression was variable within groups and 344 levels were not significantly different between the two strains of mice. 345 346 Elevated levels of several chemokines and growth factors have been implicated in fatal EBOV 347 disease outcomes including MIP-1α, MIP-1β, MCP-1, M-CSF, MIF, IP-10, GRO-α and eotaxin 348 [49] . Therefore, we analyzed control and TIM-1 -/-organs following EBOV GP∆O/rVSV 349 infection for the chemokines, CXCL10 (IP-10) and CCL2 (MCP-1). At least one of the two 350 chemokine transcripts in all three organs was elevated in the control mice at both day 3 and/or 5 351 of infection compared to the TIM-1 -/-mouse tissues (Fig. 4) . In combination with our survival 352 and viral burden results, these observations suggest that the presence of TIM-1 in mice 353 at days -1 and 2. We verified that T cells within peripheral blood were profoundly depleted at 366 day 5 of infection by flow cytometry following immunostaining with an α-CD90 mAb (Fig. 5A) . 367
As observed for the T cell-competent mice in above studies, T cell-depleted control mice 368 challenged with EBOV GP/rVSV succumbed to the infection between 4-6 days. Likewise, while 369 T cell-depleted TIM-1 -/-mice had significantly better survival than T cell depleted control mice 370 they did not exhibit improved survival over TIM-1 -/-mice that were not T cell-depleted (Fig.  371   5B ). These data provide evidence that the presence of T cells does not alter the course of this 372 acute infection and suggests that TIM-1 expression on non-T cell populations contributes to 373
pathogenesis. 374
Discussion 375
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